Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.

Crowther, M; Palumbo, Js; Kumar, R; Nurmeev, I; Hege, K; Bonnet, D; Connor, P; Hooimeijer, Hl; Torres, M; Chan, Akc; Kenet, G; Holzhauer, S; Santamaría, A; Amedro, P; Chalmers, E; Simioni, P; Bhat, Rv; Yee, Dl; Lvova, O; Beyer-Westendorf, J; Massicotte, Mp; Young, G; Pap, Af; Majumder, M; Smith, Wt; Heubach, Jf; Berkowitz, Sd; Thelen, K; Kubitza, D; Prins, Mh; Monagle, P; Eınsteın-Jr, Phase; Kállay, K; Gauger, Ca; Biss, Tt; Martinelli, I; Saracco, P; Peters, M; Male, C; Lensing, Awa

dc.contributor.author	Crowther, M
dc.contributor.author	Palumbo, Js
dc.contributor.author	Kumar, R
dc.contributor.author	Nurmeev, I
dc.contributor.author	Hege, K
dc.contributor.author	Bonnet, D
dc.contributor.author	Connor, P
dc.contributor.author	Hooimeijer, Hl
dc.contributor.author	Torres, M
dc.contributor.author	Chan, Akc
dc.contributor.author	Kenet, G
dc.contributor.author	Holzhauer, S
dc.contributor.author	Santamaría, A
dc.contributor.author	Amedro, P
dc.contributor.author	Chalmers, E
dc.contributor.author	Simioni, P
dc.contributor.author	Bhat, Rv
dc.contributor.author	Yee, Dl
dc.contributor.author	Lvova, O
dc.contributor.author	Beyer-Westendorf, J
dc.contributor.author	Massicotte, Mp
dc.contributor.author	Young, G
dc.contributor.author	Pap, Af
dc.contributor.author	Majumder, M
dc.contributor.author	Smith, Wt
dc.contributor.author	Heubach, Jf
dc.contributor.author	Berkowitz, Sd
dc.contributor.author	Thelen, K
dc.contributor.author	Kubitza, D
dc.contributor.author	Prins, Mh
dc.contributor.author	Monagle, P
dc.contributor.author	Eınsteın-Jr, Phase
dc.contributor.author	Kállay, K
dc.contributor.author	Gauger, Ca
dc.contributor.author	Biss, Tt
dc.contributor.author	Martinelli, I
dc.contributor.author	Saracco, P
dc.contributor.author	Peters, M
dc.contributor.author	Male, C
dc.contributor.author	Lensing, Awa
dc.date.accessioned	2021-03-05T13:24:49Z
dc.date.available	2021-03-05T13:24:49Z
dc.identifier.citation	Male C., Lensing A., Palumbo J., Kumar R., Nurmeev I., Hege K., Bonnet D., Connor P., Hooimeijer H., Torres M., et al., "Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.", The Lancet. Haematology, cilt.7, 2020
dc.identifier.issn	2352-3026
dc.identifier.other	vv_1032021
dc.identifier.other	av_b2184c8f-cec2-45a3-bcb3-09c663a14a95
dc.identifier.uri	http://hdl.handle.net/20.500.12627/118647
dc.identifier.uri	https://doi.org/10.1016/s2352-3026(19)30219-4
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Klinik Tıp (MED)
dc.title	Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.
dc.type	Makale
dc.relation.journal	The Lancet. Haematology
dc.contributor.department	, ,
dc.identifier.volume	7
dc.contributor.firstauthorID	2482026

Files in this item

Files	Size	Format	View
There are no files associated with this item.

This item appears in the following Collection(s)

Makale [92796]

Show simple item record